INVO Bioscience Inc
NASDAQ:INVO
INVO Bioscience Inc
NASDAQ:INVO
Price:
0.78 USD
1.3%
Market Closed
Updated:
Jun 8, 2024
INVO Bioscience Inc
Additional Paid In Capital
|
INVO Bioscience Inc
Additional Paid In Capital Peer Comparison
Comparables:
BSX
SYK
ABT
ISRG
SWAV
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
INVO Bioscience Inc
NASDAQ:INVO
|
Additional Paid In Capital
$52.9m
|
CAGR 3-Years
10%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Additional Paid In Capital
$20.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
|
Stryker Corp
NYSE:SYK
|
Additional Paid In Capital
$2.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Additional Paid In Capital
$8.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
Additional Paid In Capital
$586m
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
See Also
What is INVO Bioscience Inc's Additional Paid In Capital?
Additional Paid In Capital
52.9m
USD
52.9m
USD
Based on the financial report for Mar 31, 2024, INVO Bioscience Inc's Additional Paid In Capital amounts to 52.9m USD.
What is INVO Bioscience Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
23%
23%
Over the last year, the Additional Paid In Capital growth was 1%. The average annual Additional Paid In Capital growth rates for INVO Bioscience Inc have been 10% over the past three years , 23% over the past five years .
You don't have any saved screeners yet
